Lakewood-Amedex Biotherapeutics, Inc. (LABT)
2.69
-0.61
(-18.48%)
USD |
NASDAQ |
Jul 02, 16:00
2.80
+0.11
(+4.09%)
After-Hours: 19:45
Lakewood-Amedex Biotherapeutics Market Cap : 1.895M for July 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| July 01, 2026 | 2.324M |
| June 30, 2026 | 2.212M |
| June 29, 2026 | 2.451M |
| June 26, 2026 | 2.472M |
| June 25, 2026 | 2.416M |
| June 24, 2026 | 2.62M |
| June 23, 2026 | 2.796M |
| June 22, 2026 | 2.571M |
| June 18, 2026 | 2.719M |
| June 17, 2026 | 4.241M |
| June 16, 2026 | 5.170M |
| June 15, 2026 | 5.205M |
| June 12, 2026 | 5.405M |
| June 11, 2026 | 5.091M |
| June 10, 2026 | 5.344M |
| June 09, 2026 | 4.791M |
| June 08, 2026 | 4.510M |
| June 05, 2026 | 4.705M |
| June 04, 2026 | 4.754M |
| June 03, 2026 | 4.557M |
| June 02, 2026 | 4.367M |
| June 01, 2026 | 4.577M |
| May 29, 2026 | 4.754M |
| May 28, 2026 | 5.141M |
| May 27, 2026 | 5.165M |
| Date | Value |
|---|---|
| May 26, 2026 | 5.015M |
| May 22, 2026 | 4.977M |
| May 21, 2026 | 5.422M |
| May 20, 2026 | 5.303M |
| May 19, 2026 | 6.104M |
| May 18, 2026 | 6.692M |
| May 15, 2026 | 10.56M |
| May 14, 2026 | 13.80M |
| May 13, 2026 | 20.78M |
| May 12, 2026 | 22.68M |
| May 11, 2026 | 22.26M |
| May 08, 2026 | 21.83M |
| May 07, 2026 | 23.24M |
| May 06, 2026 | 22.04M |
| May 05, 2026 | 21.83M |
| May 04, 2026 | 22.96M |
| May 01, 2026 | 24.16M |
| April 30, 2026 | 18.73M |
| April 29, 2026 | 25.28M |
| April 28, 2026 | 27.40M |
| April 27, 2026 | 25.78M |
| April 24, 2026 | 51.77M |
| April 23, 2026 | 60.92M |
| April 22, 2026 | 56.34M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.81B |
| Oncolytics Biotech, Inc. | 104.95M |
| Sangamo Therapeutics, Inc. | 23.61M |
| Sarepta Therapeutics, Inc. | 2.036B |
| Anixa Biosciences, Inc. | 112.62M |
Market Cap Related Metrics
| PEG Ratio | -0.0031 |
| Price | 2.69 |
| Earnings Yield | -327.1% |
| PEGY Ratio | -0.0031 |